<DOC>
	<DOCNO>NCT03097783</DOCNO>
	<brief_summary>This randomize , multi-center , evaluator-blinded , no-treatment control study evaluate efficacy safety Restylane Perlane Lidocaine correction Midface Volume Deficit and/or Midface Contour Deficiency .</brief_summary>
	<brief_title>Restylane Perlane Lidocaine Correction Midface Volume Deficit and/or Midface Contour Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Signed informed consent 2 . Men woman age 18 year age old Chinese origin 3 . Subjects willing abstain facial plastic surgical cosmetic procedure level low orbital rim duration study 4 . Subjects seek augmentation therapy midface 5 . MMVS score 2 , 3 4 side face assess blinded evaluator 1 . Known/previous allergy hypersensitivity injectable HA gel/local anaesthetic , e.g.lidocaine amidetype anaesthetic . 2 . Previous surgery tattoo area treat 3 . Previous tissue augmentation therapy contour permanent ( nonbiodegradable ) semipermanent filler , autologous fat , lift thread permanent implant level lower orbital rim . 4 . Previous use hyaluronic acid base collagen base biodegradable facial tissue augmentation therapy level lower orbital rim neurotoxin within 12 month treatment . 5 . Scars deformities , active skin disease , inflammation related condition , infection , perioral dermatitis , seborrheic eczema , rosacea , acne psoriasis herpes zoster near area treat . 6 . Other condition prevent subject enter study Investigator 's opinion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hyaluronic acid , midface</keyword>
</DOC>